With the aim to evaluate the human potential therapeutic effect of FH in AD and since the APP/PS1-AD mouse model expresses two mutated human transgenes, we have chosen to inject human plasmatic FH (plFH). The gene discussed is APP; the disease is Alzheimer disease.